Cargando…
A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone
SUMMARY: We encountered a case of childhood-onset lymphocytic infundibuloneurohypophysitis, based on the MRI and endocrinological findings, with decreased function of the anterior and posterior lobes of the pituitary. Three years after the diagnosis, the patient developed non-alcoholic steatohepatit...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002206/ https://www.ncbi.nlm.nih.gov/pubmed/35319489 http://dx.doi.org/10.1530/EDM-21-0148 |
_version_ | 1784685842412863488 |
---|---|
author | Takahashi, Hidekuni Nishimata, Shigeo Kumada, Atsushi Yamanaka, Gaku Kashiwagi, Yasuyo Kawashima, Hisashi |
author_facet | Takahashi, Hidekuni Nishimata, Shigeo Kumada, Atsushi Yamanaka, Gaku Kashiwagi, Yasuyo Kawashima, Hisashi |
author_sort | Takahashi, Hidekuni |
collection | PubMed |
description | SUMMARY: We encountered a case of childhood-onset lymphocytic infundibuloneurohypophysitis, based on the MRI and endocrinological findings, with decreased function of the anterior and posterior lobes of the pituitary. Three years after the diagnosis, the patient developed non-alcoholic steatohepatitis (NASH), which was effectively treated by growth hormone (GH) supplementation. The present case demonstrated that NASH can be effectively treated by short-term GH supplementation, even in late childhood. LEARNING POINTS: In recent years, the efficacy of growth hormone replacement therapy in normalizing the liver function of adult-onset growth hormone deficiency patients with non-alcoholic steatohepatitis (NASH) has been reported. Lymphocytic infundibuloneurohypophysitis is a very rare disease, particularly in childhood. We here presented a rare case of a child with lymphocytic infundibuloneurohypophysitis who developed NASH and showed substantial improvement in liver function after growth hormone treatment. |
format | Online Article Text |
id | pubmed-9002206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-90022062022-04-12 A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone Takahashi, Hidekuni Nishimata, Shigeo Kumada, Atsushi Yamanaka, Gaku Kashiwagi, Yasuyo Kawashima, Hisashi Endocrinol Diabetes Metab Case Rep Novel Treatment SUMMARY: We encountered a case of childhood-onset lymphocytic infundibuloneurohypophysitis, based on the MRI and endocrinological findings, with decreased function of the anterior and posterior lobes of the pituitary. Three years after the diagnosis, the patient developed non-alcoholic steatohepatitis (NASH), which was effectively treated by growth hormone (GH) supplementation. The present case demonstrated that NASH can be effectively treated by short-term GH supplementation, even in late childhood. LEARNING POINTS: In recent years, the efficacy of growth hormone replacement therapy in normalizing the liver function of adult-onset growth hormone deficiency patients with non-alcoholic steatohepatitis (NASH) has been reported. Lymphocytic infundibuloneurohypophysitis is a very rare disease, particularly in childhood. We here presented a rare case of a child with lymphocytic infundibuloneurohypophysitis who developed NASH and showed substantial improvement in liver function after growth hormone treatment. Bioscientifica Ltd 2022-02-21 /pmc/articles/PMC9002206/ /pubmed/35319489 http://dx.doi.org/10.1530/EDM-21-0148 Text en © The authors https://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Novel Treatment Takahashi, Hidekuni Nishimata, Shigeo Kumada, Atsushi Yamanaka, Gaku Kashiwagi, Yasuyo Kawashima, Hisashi A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone |
title | A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone |
title_full | A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone |
title_fullStr | A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone |
title_full_unstemmed | A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone |
title_short | A 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone |
title_sort | 17-year-old boy with lymphocytic infundibuloneurohypophysitis who developed non-alcoholic steatohepatitis effectively treated with growth hormone |
topic | Novel Treatment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002206/ https://www.ncbi.nlm.nih.gov/pubmed/35319489 http://dx.doi.org/10.1530/EDM-21-0148 |
work_keys_str_mv | AT takahashihidekuni a17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone AT nishimatashigeo a17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone AT kumadaatsushi a17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone AT yamanakagaku a17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone AT kashiwagiyasuyo a17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone AT kawashimahisashi a17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone AT takahashihidekuni 17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone AT nishimatashigeo 17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone AT kumadaatsushi 17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone AT yamanakagaku 17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone AT kashiwagiyasuyo 17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone AT kawashimahisashi 17yearoldboywithlymphocyticinfundibuloneurohypophysitiswhodevelopednonalcoholicsteatohepatitiseffectivelytreatedwithgrowthhormone |